Ta Khoa and his colleagues have studied the prognostic value of SLC35 family in breast cancer (BRCA) accompanied by the correlation with tumor immune invasion [11], illustrating that SLC35A2 expression was not only associated with poor recurrence-free survival rate, but also the macrophage and neutrophil infiltration levels and multiple subtypes of BCRA, supporting the potential role of SLC35A2 in the development of various cancers. This evidence concerns the gene SLC35A2 and cancer.